GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » 3-Year EPS without NRI Growth Rate

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) 3-Year EPS without NRI Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co 3-Year EPS without NRI Growth Rate?

Tonghua Golden-horse Pharmaceutical Industry Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.01.

During the past 12 months, Tonghua Golden-horse Pharmaceutical Industry Co's average EPS without NRI Growth Rate was 80.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Tonghua Golden-horse Pharmaceutical Industry Co was 180.20% per year. The lowest was -54.30% per year. And the median was 1.40% per year.


Competitive Comparison of Tonghua Golden-horse Pharmaceutical Industry Co's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Tonghua Golden-horse Pharmaceutical Industry Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonghua Golden-horse Pharmaceutical Industry Co's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tonghua Golden-horse Pharmaceutical Industry Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Tonghua Golden-horse Pharmaceutical Industry Co's 3-Year EPS without NRI Growth Rate falls into.



Tonghua Golden-horse Pharmaceutical Industry Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Tonghua Golden-horse Pharmaceutical Industry Co  (SZSE:000766) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Tonghua Golden-horse Pharmaceutical Industry Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines